FDA finds no cancer link with blood pressure pills

Jun 02, 2011

(AP) -- The Food and Drug Administration says there is no link between a popular group of blood pressure medications and cancer, despite a recent paper suggesting a slightly higher risk in patients taking the drugs.

In an analysis of 60,000 patients published last summer, experts found a link between people taking medicines known as angiotensin-receptor blockers and cancer. The drugs are taken by millions of people worldwide for conditions like , heart problems and .

But the FDA says its own review of 31 studies involving 155,000 patients did not show any relationship between the drugs and cancer. The review is the largest of its kind, according to the FDA

The drugs are sold under brand names including Diovan, Micardis and Avapro.

Explore further: Teva to lift bid for Mylan: report

0 shares

Related Stories

FDA panel backs anemia drugs for kidney disease

Oct 18, 2010

(AP) -- Federal health advisers say patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.

FDA: Arthritis drugs pose cancer risk to children

Aug 04, 2009

(AP) -- Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.

FDA questions safety of Glaxo kidney cancer drug

Oct 01, 2009

(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.

High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, ...

Recommended for you

Teva to lift bid for Mylan: report

18 hours ago

Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.

Vaccine for West Nile Virus enters human clinical trials

23 hours ago

A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.